156 related articles for article (PubMed ID: 27701016)
1. Structural properties and release of insulin-loaded reverse hexagonal (HII) liquid crystalline mesophase.
Mishraki-Berkowitz T; Aserin A; Garti N
J Colloid Interface Sci; 2017 Jan; 486():184-193. PubMed ID: 27701016
[TBL] [Abstract][Full Text] [Related]
2. The dielectric study of insulin-loaded reverse hexagonal (H(II)) liquid crystals.
Mishraki-Berkowitz T; Ben Ishai P; Aserin A; Feldman Y; Garti N
Phys Chem Chem Phys; 2015 Apr; 17(14):9499-508. PubMed ID: 25767829
[TBL] [Abstract][Full Text] [Related]
3. Controlling insulin release from reverse hexagonal (H
Mishraki-Berkowitz T; Cohen G; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2018 Jan; 161():670-676. PubMed ID: 29172155
[TBL] [Abstract][Full Text] [Related]
4. Modulation of physical properties of reverse hexagonal mesophases: a dielectric spectroscopy study.
Mishraki T; Ben Ishai P; Babukh D; Aserin A; Feldman Y; Garti N
J Colloid Interface Sci; 2013 Apr; 396():178-86. PubMed ID: 23415506
[TBL] [Abstract][Full Text] [Related]
5. The role of glycerol and phosphatidylcholine in solubilizing and enhancing insulin stability in reverse hexagonal mesophases.
Amar-Yuli I; Azulay D; Mishraki T; Aserin A; Garti N
J Colloid Interface Sci; 2011 Dec; 364(2):379-87. PubMed ID: 21958442
[TBL] [Abstract][Full Text] [Related]
6. Formulation and characterization of a liquid crystalline hexagonal mesophase region of phosphatidylcholine, sorbitan monooleate, and tocopherol acetate for sustained delivery of leuprolide acetate.
Báez-Santos YM; Otte A; Mun EA; Soh BK; Song CG; Lee YN; Park K
Int J Pharm; 2016 Nov; 514(1):314-321. PubMed ID: 27863678
[TBL] [Abstract][Full Text] [Related]
7. Structural effects of insulin-loading into HII mesophases monitored by electron paramagnetic resonance (EPR), small angle X-ray spectroscopy (SAXS), and attenuated total reflection Fourier transform spectroscopy (ATR-FTIR).
Mishraki T; Ottaviani MF; Shames AI; Aserin A; Garti N
J Phys Chem B; 2011 Jun; 115(25):8054-62. PubMed ID: 21591776
[TBL] [Abstract][Full Text] [Related]
8. Lysozyme entrapped within reverse hexagonal mesophases: physical properties and structural behavior.
Mishraki T; Libster D; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):47-56. PubMed ID: 19748240
[TBL] [Abstract][Full Text] [Related]
9. Molecular interactions in reverse hexagonal mesophase in the presence of Cyclosporin A.
Libster D; Ishai PB; Aserin A; Shoham G; Garti N
Int J Pharm; 2009 Feb; 367(1-2):115-26. PubMed ID: 18977286
[TBL] [Abstract][Full Text] [Related]
10. Phase transition and release kinetics of polyphenols encapsulated lyotropic liquid crystals.
Zhang H; Wang Z
Int J Pharm; 2019 Jun; 565():283-293. PubMed ID: 31078646
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization of lyotropic liquid crystals containing a dendrimer for solubilization and release of gallic acid.
Bitan-Cherbakovsky L; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2013 Dec; 112():87-95. PubMed ID: 23973908
[TBL] [Abstract][Full Text] [Related]
12. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
Libster D; Aserin A; Garti N
J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
[TBL] [Abstract][Full Text] [Related]
13. Oil and drug control the release rate from lyotropic liquid crystals.
Martiel I; Baumann N; Vallooran JJ; Bergfreund J; Sagalowicz L; Mezzenga R
J Control Release; 2015 Apr; 204():78-84. PubMed ID: 25744826
[TBL] [Abstract][Full Text] [Related]
14. Cubic Liquid Crystalline Gels Based on Glycerol Monooleate for Intra-articular Injection.
Li Q; Cao J; Li Z; Chu X
AAPS PharmSciTech; 2018 Feb; 19(2):858-865. PubMed ID: 29027137
[TBL] [Abstract][Full Text] [Related]
15. Lipolysis and structure controlled drug release from reversed hexagonal mesophase.
Garti N; Hoshen G; Aserin A
Colloids Surf B Biointerfaces; 2012 Jun; 94():36-43. PubMed ID: 22341515
[TBL] [Abstract][Full Text] [Related]
16. Complex dendrimer-lyotropic liquid crystalline systems: structural behavior and interactions.
Bitan-Cherbakovsky L; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Oct; 115(42):11984-92. PubMed ID: 21902258
[TBL] [Abstract][Full Text] [Related]
17. The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery system.
Otte A; Báez-Santos YM; Mun EA; Soh BK; Lee YN; Park K
Int J Pharm; 2017 Oct; 532(1):345-351. PubMed ID: 28844902
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
Milak S; Chemelli A; Glatter O; Zimmer A
Eur J Pharm Biopharm; 2019 Jun; 139():279-290. PubMed ID: 31002864
[TBL] [Abstract][Full Text] [Related]
19. Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac.
Cohen-Avrahami M; Libster D; Aserin A; Garti N
J Control Release; 2012 May; 159(3):419-28. PubMed ID: 22306174
[TBL] [Abstract][Full Text] [Related]
20. Reversed hexagonal lyotropic liquid-crystal and open-shell glycodendrimers as potential vehicles for sustained release of sodium diclofenac.
Bitan-Cherbakovsky L; Libster D; Appelhans D; Voit B; Aserin A; Garti N
J Phys Chem B; 2014 Apr; 118(14):4016-24. PubMed ID: 24617448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
